bluebird bio, Inc. (117) | Business Finance (11)

Browse by Subcategory

Equity Distribution Agreements (1 contract)
Purchase Agreements (4)
Registration Rights Agreements (2)
Share Agreements (1)
Underwriting Agreements (2)
Warrant Agreements (1)

Recent Contracts

Underwriting Agreement, dated as of January 18, 2023, by and among bluebird bio, Inc., Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (Filed With SEC on January 19, 2023)
Asset Purchase Agreement, dated as of January 5, 2023, by and between bluebird bio, Inc. and Bristol-Myers Squibb Company (Filed With SEC on January 6, 2023)
Asset Purchase Agreement, dated as of November 29, 2022, by and between bluebird bio, Inc. and argenx BV (Filed With SEC on November 30, 2022)
Equity Distribution Agreement, dated as of June 22, 2022, by and between bluebird bio, Inc. and Goldman Sachs & Co. LLC (Filed With SEC on June 22, 2022)
Securities Purchase Agreement, dated September 7, 2021, by and among the Registrant and the institutional investors named therein (Filed With SEC on November 5, 2021)
Registration Rights Agreement, dated September 7, 2021, by and among the Registrant and the persons listed on the attached Schedule A thereto (Filed With SEC on November 5, 2021)
Form of Pre-Funded Warrant (Filed With SEC on September 8, 2021)
Securities Purchase Agreement, dated September 7, 2021, by and among the Company and the institutional investors named therein (Filed With SEC on September 8, 2021)
Registration Rights Agreement, dated September 7, 2021, by and between the Company and the persons listed on the attached Schedule A thereto (Filed With SEC on September 8, 2021)
First Amendment to Amended and Restated Co-Development, Co-Promote and Profit Share Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment... (Filed With SEC on August 5, 2020)
Underwriting Agreement, dated as of May 18, 2020, among bluebird bio, Inc. and Goldman Sachs & Co. LLC, BofA Securities, Inc. and Cowen and Company, LLC, as representatives of the... (Filed With SEC on May 19, 2020)